Daniela Basso

Summary

Affiliation: University Hospital
Country: Italy

Publications

  1. ncbi Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study
    Daniela Basso
    Department of Medicine, University of Padova, Padova, Italy
    PLoS ONE 8:e54824. 2013
  2. ncbi Pathogenesis of Helicobacter pylori infection
    Daniela Basso
    Department of Laboratory Medicine, University Hospital of Padova, Via Giustiniani 2, Padua, Italy
    Helicobacter 15:14-20. 2010
  3. ncbi Clarithromycin resistance, tumor necrosis factor alpha gene polymorphism and mucosal inflammation affect H. pylori eradication success
    Carlo Federico Zambon
    Department of Medical and Surgical Sciences, University of Padova, Padova, Italy
    J Gastrointest Surg 11:1506-14; discussion 1514. 2007
  4. ncbi Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms
    Daniela Basso
    Department of Laboratory Medicine, University of Padova, Padova, Italy
    Gastroenterology 135:91-9. 2008
  5. ncbi Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome
    Carlo F Zambon
    Department of Medical and Surgical Sciences, University of Padua, Via Giustiniani 2, 35128 Padua, Italy
    Cytokine 29:141-52. 2005
  6. ncbi Oxidative DNA damage in gastric cancer: CagA status and OGG1 gene polymorphism
    Fabio Farinati
    Dipartimento di Scienze Chirurgiche e Gastroenterologiche, Universita di Padova, Padova, Italy
    Int J Cancer 123:51-5. 2008
  7. ncbi Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children
    Daniela Basso
    Department of Laboratory Medicine, University of Padova, Italy
    Clin Chem 55:150-7. 2009
  8. ncbi Mitochondrial DNA D-loop in pancreatic cancer: somatic mutations are epiphenomena while the germline 16519 T variant worsens metabolism and outcome
    Filippo Navaglia
    Department of Laboratory Medicine, University of Padova, Italy
    Am J Clin Pathol 126:593-601. 2006
  9. ncbi IL-4 -588C>T polymorphism and IL-4 receptor alpha [Ex5+14A>G; Ex11+828A>G] haplotype concur in selecting H. pylori cagA subtype infections
    Carlo Federico Zambon
    Department of Medical and Surgical Sciences, University of Padova, Italy
    Clin Chim Acta 389:139-45. 2008
  10. ncbi Non-invasive diagnosis of Helicobacter pylori infection: simplified 13C-urea breath test, stool antigen testing, or DNA PCR in human feces in a clinical laboratory setting?
    Carlo Federico Zambon
    Department of Medical and Surgical Sciences, University of Padova, Italy
    Clin Biochem 37:261-7. 2004

Collaborators

Detail Information

Publications42

  1. ncbi Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study
    Daniela Basso
    Department of Medicine, University of Padova, Padova, Italy
    PLoS ONE 8:e54824. 2013
    ....
  2. ncbi Pathogenesis of Helicobacter pylori infection
    Daniela Basso
    Department of Laboratory Medicine, University Hospital of Padova, Via Giustiniani 2, Padua, Italy
    Helicobacter 15:14-20. 2010
    ..Among those are studies on the genetic variation of genes encoding outer membrane proteins and the mimicry of host antigens, factors that alter host-cell metabolism and factors that modulate the host's immune response...
  3. ncbi Clarithromycin resistance, tumor necrosis factor alpha gene polymorphism and mucosal inflammation affect H. pylori eradication success
    Carlo Federico Zambon
    Department of Medical and Surgical Sciences, University of Padova, Padova, Italy
    J Gastrointest Surg 11:1506-14; discussion 1514. 2007
    ....
  4. ncbi Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms
    Daniela Basso
    Department of Laboratory Medicine, University of Padova, Padova, Italy
    Gastroenterology 135:91-9. 2008
    ..We assessed the association of new and established cagA and vacA polymorphisms with disease...
  5. ncbi Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome
    Carlo F Zambon
    Department of Medical and Surgical Sciences, University of Padua, Via Giustiniani 2, 35128 Padua, Italy
    Cytokine 29:141-52. 2005
    ..In conclusion, among host genetic factors contributing to H. pylori disease outcome, IFN-G +874 AA genotype favors cagA positive infections, TNF-A -857 TT duodenal ulcer while IL-10 -819 TT intestinal metaplasia and NCGC...
  6. ncbi Oxidative DNA damage in gastric cancer: CagA status and OGG1 gene polymorphism
    Fabio Farinati
    Dipartimento di Scienze Chirurgiche e Gastroenterologiche, Universita di Padova, Padova, Italy
    Int J Cancer 123:51-5. 2008
    ..OGG1 1245C-->G polymorphism was common in both GC and IMA, but very rare in controls, and correlated more closely with 8-OHdG levels than do H. pylori infection or cagA status...
  7. ncbi Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children
    Daniela Basso
    Department of Laboratory Medicine, University of Padova, Italy
    Clin Chem 55:150-7. 2009
    ..AGA IgA II and AGA IgG II have recently been suggested as reliable tools for celiac disease (CD) diagnosis. We compared their utility for diagnosis and monitoring CD in children with that of tTG IgA, an established CD marker...
  8. ncbi Mitochondrial DNA D-loop in pancreatic cancer: somatic mutations are epiphenomena while the germline 16519 T variant worsens metabolism and outcome
    Filippo Navaglia
    Department of Laboratory Medicine, University of Padova, Italy
    Am J Clin Pathol 126:593-601. 2006
    ....
  9. ncbi IL-4 -588C>T polymorphism and IL-4 receptor alpha [Ex5+14A>G; Ex11+828A>G] haplotype concur in selecting H. pylori cagA subtype infections
    Carlo Federico Zambon
    Department of Medical and Surgical Sciences, University of Padova, Italy
    Clin Chim Acta 389:139-45. 2008
    ..pylori virulence genes or H. pylori associated diseases...
  10. ncbi Non-invasive diagnosis of Helicobacter pylori infection: simplified 13C-urea breath test, stool antigen testing, or DNA PCR in human feces in a clinical laboratory setting?
    Carlo Federico Zambon
    Department of Medical and Surgical Sciences, University of Padova, Italy
    Clin Biochem 37:261-7. 2004
    ..2) To ascertain whether a simplified UBT (breath collection time = 10 min) is as reliable as the standard assay (30 min)...
  11. ncbi Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer
    Paola Fogar
    Department of Medical and Surgical Sciences, University of Padova, Padova, Italy
    Pancreas 35:224-31. 2007
    ..We ascertained whether gene therapy with FCY1-FUR1 is effective in killing pancreatic cancer cells after 5-fluorocytosine (5-FC) treatment...
  12. ncbi Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease
    Marco Scarpa
    Clinica Chirurgica I, Dipartimento di Scienze Chirurgiche e Gastroenterologiche, University of Padova, Padova, Italy
    Dis Colon Rectum 50:861-9. 2007
    ..This study was designed to assess the role of fecal lactoferrin and calprotectin as markers of intestinal inflammation in patients with Crohn's disease who have undergone ileocolonic resection...
  13. ncbi Molecular refinement of clinical staging in hepatocellular carcinoma patients evaluated for potentially curative therapies
    Alessandro Vitale
    Unità di Chirurgia Epatobiliare e Trapianto Epatico, Dipartimento di Chirurgia Generale e Trapianti d Organo, Universita di Padova, Padova, Italy
    PLoS ONE 6:e23093. 2011
    ..VEGF and AFP mRNA determinations in the blood are promising prognostic factors for patients with HCC. This study explores their potential prognostic synergy in a cohort of HCC patients evaluated for potentially curative therapies...
  14. ncbi Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications
    Eliana Greco
    Department of Laboratory Medicine, University of Padova, Padova, Italy
    Pancreas 39:662-8. 2010
    ....
  15. ncbi Altered intracellular calcium fluxes in pancreatic cancer induced diabetes mellitus: Relevance of the S100A8 N-terminal peptide (NT-S100A8)
    Daniela Basso
    Department of Laboratory Medicine, University of Padua, Padua, Italy
    J Cell Physiol 226:456-68. 2011
    ....
  16. ncbi Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry
    Filippo Navaglia
    Department of Laboratory Medicine, University of Padova, Padova, Italy
    Clin Chem Lab Med 47:713-23. 2009
    ..The aim of the present study was to explore the application of SELDI proteomic patterns in serum for distinguishing between cases of pancreatic cancer, chronic pancreatitis, type 2 diabetes mellitus and healthy controls...
  17. ncbi Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides
    Anna Valerio
    Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy
    Clin Chim Acta 343:119-27. 2004
    ..CONCLUSIONS: Unlike liver GAPDH, NO appears to be involved in PC associated DM. In portal sera, the absence, rather than the presence, of specific fragments, appears to be correlated with the development of DM...
  18. ncbi DNA repair pathways and mitochondrial DNA mutations in gastrointestinal carcinogenesis
    Daniela Basso
    Department of Laboratory Medicine, University Hospital of Padova, Via Giustiniani 2, 35128 Padova, Italy
    Clin Chim Acta 381:50-5. 2007
    ....
  19. ncbi Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause?
    Daniela Basso
    Department of Laboratory Medicine, University of Padua, Via Giustiniani 2, 35128 Padova, Italy
    Clin Chim Acta 372:120-8. 2006
    ..Our aim was to identify the pancreatic cancer diabetogenic peptide...
  20. ncbi Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome
    Paola Fogar
    Department of Medical and Surgical Sciences, University of Padova, Padova, Italy
    Pancreas 32:22-8. 2006
    ....
  21. ncbi Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications
    Daniela Basso
    Department of Laboratory Medicine, University of Padova, Via Giustiniani 2, Padova 35128, Italy
    Clin Chim Acta 357:184-9. 2005
    ..CONCLUSIONS: We identified a tumor-derived peptide of 14 amino acids sharing a 100% homology with an S-100 calcium binding protein, which is probably the pancreatic cancer-associated diabetogenic factor...
  22. ncbi Effectiveness of the combined evaluation of KLK3 genetics and free-to-total prostate specific antigen ratio for prostate cancer diagnosis
    Carlo Federico Zambon
    Department of Laboratory Medicine, University of Padova, Padova, Italy
    J Urol 188:1124-30. 2012
    ..We ascertained whether the knowledge of KLK3 genetics would enhance prostate specific antigen diagnostic performance in patients with clinical suspicion of prostate cancer...
  23. ncbi Usefulness of MALDI-TOF/MS Identification of Low-MW Fragments in Sera for the Differential Diagnosis of Pancreatic Cancer
    Andrea Padoan
    From the Department of Laboratory Medicine, University of Padova CNR ISTM Departments of Surgical Oncological and Gastroenterological Sciences DiSCOG and Medicine DIMED, University of Padova, Padova First Division of General Surgery, University of Verona, Verona General Surgery, Pieve di Coriano Hospital, Mantova and SIPRES, Gruppo Pavanello, Padova, Italy
    Pancreas 42:622-32. 2013
    ..To identify new biomarkers of pancreatic cancer (PaCa), we performed MALDI-TOF/MS analysis of sera from 22 controls, 51 PaCa, 37 chronic pancreatitis, 24 type II diabetes mellitus (DM), 29 gastric cancer (GC), and 24 chronic gastritis (CG)...
  24. ncbi Retrovirus-mediated herpes simplex virus thymidine kinase gene transfer in pancreatic cancer cell lines: an incomplete antitumor effect
    Eliana Greco
    Department of Laboratory Medicine, University of Padova, Padova, Italy
    Pancreas 25:e21-9. 2002
    ..CONCLUSION: Gene therapy with HSV-TK for pancreatic cancer seems effective in only a limited number of tumor-derived cell lines, and this limits its application in vivo...
  25. ncbi Helicobacter pylori infection in children and adults: a single pathogen but a different pathology
    Nicoletta Gallo
    Department of Laboratory Medicine, University of Padova, Italy
    Helicobacter 8:21-8. 2003
    ..The most virulent cagA positive H. pylori colonizes not only the gastric, but also the duodenal mucosa, which can be directly damaged by the bacteria itself or by its products...
  26. ncbi New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis
    Daniela Basso
    Department of Laboratory Medicine, University of Padova, Padova, Italy
    Clin Chim Acta 412:1662-7. 2011
    ..We compared the diagnostic accuracy of three new tests proposed for CD screening with that of the well established IgA tTG, and ascertained whether any combination of these tools might enhance accuracy in diagnosing CD...
  27. ncbi Immunotherapy for gastric premalignant lesions and cancer
    Valerio Zorzetto
    Department of Surgical, Oncological and Gastroenterological Sciences, Policlinico Universitario, Via Giustiniani 2, 35128 Padova, Italy
    Immunotherapy 4:587-99. 2012
    ..No study on immunotherapy of carcinoids is available but, in our experience, the administration of an antigastrin 17 vaccine induced carcinoid regression in two out of three patients treated...
  28. ncbi VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study
    Carlo Federico Zambon
    Department of Laboratory Medicine, University Hospital of Padua, 35128 Padua, Italy
    Pharmacogenomics 12:15-25. 2011
    ..A total of 371 patients under stable warfarin therapy were retrospectively selected to develop a pharmacogenetic algorithm to identify the individual maintenance dose...
  29. ncbi Decreased expression and promoter methylation of the menin tumor suppressor in pancreatic ductal adenocarcinoma
    Ilaria Cavallari
    Department of Oncology and Surgical Sciences, University of Padova, Via Gattamelata 64, Padova 35128, Italy
    Genes Chromosomes Cancer 48:383-96. 2009
    ..These findings represent the first evidence that the MEN1 gene is a target of mutation and methylation in PDAC and that menin influences the cell cycle profile of duct cells...
  30. ncbi Quantitative PSA mRNA determination in blood: a biochemical tool for scoring localized prostate cancer
    Carlo-Federico Zambon
    Department of Medical and Surgical Sciences, University of Padova, Padua, Italy
    Clin Biochem 39:333-8. 2006
    ..CONCLUSIONS: tPSA and f/t PSA are the best available tools for discriminating between localized PC and BPH. The quantitative assessment of PSA mRNA in blood might be helpful in the biochemical grading of prostate cancer...
  31. ncbi Pancreatic cancer alters human CD4+ T lymphocyte function: a piece in the immune evasion puzzle
    Paola Fogar
    Department of Laboratory Medicine, University of Padova, Padova, Italy
    Pancreas 40:1131-7. 2011
    ....
  32. ncbi Celiac disease in North Italian patients with autoimmune thyroid diseases
    Aglaura Cinzia Spadaccino
    Division of Endocrinology, Department of Medical and Surgical Sciences, University of Padova Medical School, Padova, Italy
    Autoimmunity 41:116-21. 2008
    ..An IgA deficiency is the most frequent immunodeficiency in humans and, in general, high frequency of this disorder was demonstrated in those with autoimmune diseases...
  33. ncbi H. pylori infection: bacterial virulence factors and cytokine gene polymorphisms as determinants of infection outcome
    Daniela Basso
    Department of Laboratory Medicine, University Hospital of Padova, Padova, Italy
    Crit Rev Clin Lab Sci 41:313-37. 2004
    ..pylori infection. This review focuses on the role of H. pylori virulence genes and on host cytokines' genes polymorphisms in determining clinical outcome to H. pylori infection...
  34. ncbi A new indirect chemiluminescent immunoassay to measure anti-tissue transglutaminase antibodies
    Daniela Basso
    Department of Laboratory Medicine, University of Padova, Padova, Italy
    J Pediatr Gastroenterol Nutr 43:613-8. 2006
    ..The anti-tTG test correlates with the degree of mucosal destruction and is suitable for verifying patient compliance to dietary treatment...
  35. ncbi Gastric type I carcinoid: a pilot study with human G17DT immunogen vaccination
    Chiara Tieppo
    Department of Surgical and Gastroenterological Sciences, Policlinico Universitario, Via Giustiniani 2, Padua, Italy
    Cancer Immunol Immunother 60:1057-60. 2011
    ..The approach to treatment, either endoscopic, medical or surgical, is not well defined, particularly in multifocal tumours or carcinoids with rapid growth/frequent recurrence...
  36. ncbi Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma
    Umberto Cillo
    Clinica Chirurgica I, Department of Surgical and Gastroenterological Sciences, University of Padua, School of Medicine, Via Giustiniani 2, Policlinico III Piano, 35128 Padova, Italy
    Clin Chim Acta 347:129-38. 2004
    ....
  37. ncbi Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms
    Carlo-Federico Zambon
    Departments of Medical and Surgical Sciences, Laboratory Medicine, Oncological and Surgical Sciences, Gastroenterology, and Pathology, University of Padova, Padova, Italy
    Gastroenterology 126:382-4. 2004
  38. ncbi Non-invasive assessment of chronic liver and gastric diseases
    Mario Plebani
    Department of Laboratory Medicine, University Hospital of Padova, Italy
    Clin Chim Acta 381:39-49. 2007
    ..In these patients, precise definition of the hepatic fibrosis stage is the most important parameter to assess the risk of disease progression and to decide for an immediate and appropriate antiviral therapy...
  39. ncbi Enzymes in feces: useful markers of chronic inflammatory bowel disease
    Imerio Angriman
    Clinica Chirurgica I, Dipartimento di Scienze Chirurgiche e Gastroenterologiche, University of Padova, Italy
    Clin Chim Acta 381:63-8. 2007
    ..Ulcerative colitis and Crohn's disease are characterized by a chronic intestinal inflammation. Since the precise etiology is still unknown, current therapies are aimed at reducing or eliminating inflammation...
  40. ncbi Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload
    Annarosa Floreani
    Department of Surgical and Gastroenterological Sciences, University of Padova, Padova, Italy
    Clin Chem Lab Med 49:197-206. 2011
    ..The aims of the study were 1) to assess the performance of this method in different conditions of iron metabolism disorders; 2) to assess the diagnostic validity of non-invasive serum biomarkers in the identification of iron overload...
  41. ncbi Putative pancreatic cancer-associated diabetogenic factor: 2030 MW peptide
    Daniela Basso
    Department of Laboratory Medicine, University of Padova, Italy
    Pancreas 24:8-14. 2002
    ..Only the peptide at m/z 2030 was found to be associated with the presence of diabetes. CONCLUSION: A peptide at m/z 2030 may be a putative pancreatic cancer-associated diabetogenic factor...
  42. ncbi Efficacy of zinc supplementation in preventing acute hepatitis in Long-Evans Cinnamon rats
    Valentina Medici
    Section of Gastroenterology, Department of Surgical and Gastroenterological Sciences, University of Padova, Italy
    Liver Int 25:888-95. 2005
    ..8-hydroxy-2'-deoxyguanosine amounts were significantly lower in untreated rats. CONCLUSIONS: Zn acetate prevents acute hepatitis, by increasing tissue MT concentrations, reducing Cu absorption and interfering with Fe metabolism...